Examining Meibomian Gland Function in Patients with Renal Anemia
Function and Morphological Characteristics of Meibomian Gland in Patients With Renal Anemia
This study is testing how renal anemia affects the meibomian glands and dry eye symptoms in patients receiving different treatments.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Zhongnan Hospital Academic / other |
| Locations | 1 site (Wuhan, Hubei) |
| Trial ID | NCT06287879 on ClinicalTrials.gov |
What this trial studies
This study investigates the function and morphological characteristics of the meibomian gland in patients suffering from renal anemia who exhibit dry eye symptoms. It involves collecting medical histories and conducting dry eye examinations on patients treated with either Roxadustat or erythropoietin. The study aims to analyze various parameters such as lacrimal river height, tear film rupture time, and meibomian gland grade to understand the impact of renal anemia on ocular health. Statistical analysis will be performed to evaluate the findings and draw conclusions about the relationship between renal anemia and meibomian gland dysfunction.
Who should consider this trial
Good fit: Ideal candidates include patients with renal anemia who have been using Roxadustat or erythropoietin for treatment.
Not a fit: Patients who wear contact lenses, have a history of eye surgeries, or have systemic health conditions affecting ocular health may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and management of dry eye symptoms in patients with renal anemia.
How similar studies have performed: While there may be studies on dry eye and meibomian gland dysfunction, this specific focus on renal anemia is relatively novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * long-term use of Roxadustat or erythropoietin for renal anemia Exclusion Criteria: * contact lens wearer, history of eye surgeries, systemic health conditions affecting ocular health and those who were unable to cooperate with examinations
Where this trial is running
Wuhan, Hubei
- Zhongnan Hospital of Wuhan University — Wuhan, Hubei, China (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.